1. Adamson, R.H., E.G. Snyderwine, U.P. Thorgeirsson, H.A. Schut, R.J. Turesky, S.S. Thorgeirsson, S. Takayama and T. Sugimura (1995) Metabolic processing and carcinogenicity of heterocyclic amines in nonhuman primates, Int. Symp. Princess Takamatsu Cancer Research Fund, 21, 289–301.
2. Boobis, A.R., A.M. Lynch, S. Murray, R. de la Torre, A. Solans, M. Farre, J. Segura, N.J. Gooderham and D.S. Davies. (1994) CYP1A2 catalysed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans, Cancer Res., 54, 89–94.
3. Brooks, R.A., N.J. Gooderham, K. Zhao, R.J. Edwards, L.A. Howard, A.R. Boobis and D.J. Winton (1994) 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is a potent mutagen in the mouse small intestine, Cancer Res., 54, 1665–1667.
4. Buonarati, M.H., K.W. Turtletaub, N.H. Shen and J.R. Felton (1990) Role of sulfation and acetylation in the activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine to intermediates which bind to DNA, Mutat. Res., 245, 185–190.
5. Chen, R.H., V.M. Maher, J. Brouwer, P. Van de Putte and J.J. McCormick (1992) Preferential repair and strand-specific repair of benzo[a]pyrene diol epoxide adducts in the hgprt gene of diploid human fibroblasts, Proc. Natl. Acad. Sci. USA, 89, 5413–5417.